PRESS RELEASE published on 03/04/2024 at 07:00, 6 months 16 days ago ARYZTA on track to deliver mid-term targets ARYZTA AG is on track to deliver its mid-term targets, according to the ad hoc announcement released. ARYZTA is an international bakery company headquartered in Switzerland, listed on the SIX Swiss Exchange Ad Hoc Announcement SIX Swiss Exchange ARYZTA AG Mid-term Targets International Bakery Company
PRESS RELEASE published on 11/08/2023 at 07:00, 10 months 12 days ago Jörg Riboni and Gordon Hardie resign from ARYZTA AG Board
PRESS RELEASE published on 11/03/2023 at 19:42, 10 months 17 days ago Board of Directors appoint Heiner Kamps as Lead Independent Director
PRESS RELEASE published on 10/09/2023 at 07:00, 11 months 11 days ago ARYZTA repurchases CHF120.3m of its CHF Hybrid Bonds
PRESS RELEASE published on 10/02/2023 at 07:00, 11 months 18 days ago Profitability continues to improve; €2.1b revenue, 12.8% EBITDA margin and €112m of profit for the period; ROIC of 10.2% back in value creation territory
Published on 09/20/2024 at 23:40, 7 hours 5 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 7 hours 15 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 7 hours 45 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 8 hours 15 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 8 hours 30 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 7 hours 46 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 9 hours 45 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 10 hours 30 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 10 hours 55 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 10 hours 58 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 13 hours 5 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 13 hours 5 minutes ago Mise à disposition du Rapport Financier Semestriel 2024